Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety

Author:

Regulska KatarzynaORCID,Musiał JoannaORCID,Stanisz Beata J.ORCID

Abstract

High global expenditure on out-of-label-date drugs, along with safety concerns associated with the accumulation of degradation impurities, justify the need for stability profiling. In this article, a comprehensive study on the solid-state stability of ramipril (RAM) was performed via isothermal methods under stress conditions. A validated stability-indicating HPLC protocol was used. The effects of various factors on the rate of RAM degradation were investigated, including: temperature, relative air humidity (RH), excipients (talc, starch, methylcellulose and hydroxypropyl methylcellulose), mode of tablet storage, and immediate packaging. The degradation impurities were also identified by HPLC–MS. It was found that RAM was unstable, and temperature accelerated its degradation. RAM was also vulnerable to RH changes, suggesting that it must be protected from moisture. The reaction followed first-order kinetics. The studied excipients stabilized RAM as a pure substance. The tableting process deteriorated its stability, explaining the need for appropriate immediate packaging. RAM in the form of tablets must be stored in blisters, and it cannot be crushed into two halves. The degradation impurities were ramiprilat and the diketopiperazine derivative.

Funder

Greater Poland Cancer Center

Poznan University of Medical Sciences

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference25 articles.

1. A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates

2. Stability testing of pharmaceutical products;Bajaj;Int. J. Appl. Pharm. Sci. Res.,2012

3. The European Medicines Agency’s Scientific Guidelines on the Stability of Drug Substances and Drug Products Help Medicine Developers Prepare Marketing Authorisation Applications for Human Medicineshttps://www.ema.europa.eu/en/human-regulatory/research-development/scientific-guidelines/quality/quality-stability

4. The European Medicines Agency’s Scientific Guidelines on Impurities in Drug Products and Drug Substances Help Medicine Developers Prepare Marketing Authorisation Applications for Human Medicineshttps://www.ema.europa.eu/en/human-regulatory/research-development/scientific-guidelines/quality/quality-impurities

5. ICH M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Riskhttps://www.ema.europa.eu/documents/scientific-guideline/ich-guideline-m7r1-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit_en.pdf

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3